Skip to content
GLP-1 Decoder

Trulicity Hypoglycemia: How Common, How Long It Lasts

The Trulicity label names hypoglycemia as a reported side effect but gives no trial rate for it.

In the label
Listed, no rate given
Label term
hypoglycemia

Trulicity overview

Time it remains in the body
100%50%25%0%05 d10 d15 d20 d25 d50%25%12.5%time after the dose

The half-life is about 5 days: after 5 d, half is gone, and about 3% remains after five half-lives (25 d).

Sources: FDA label (DailyMed).

What the Trulicity label provides instead

The Trulicity label gives no rate for low blood sugar. Rates are provided for the five most common side effects listed in the label.

Table 1: In TRULICITY-Treated Adult Patients with Type 2 Diabetes Mellitus, Adverse Reactions in Pool of Placebo-Controlled Trials That Occurred in ≥5%
Side effectPlaceboTrulicity 0.75 mgTrulicity 1.5 mgMore than placebo, 1.5 mg
Nausea5.3%12.4%21.1%+15.8 points
Vomiting2.3%6%12.7%+10.4 points
Diarrhea6.7%8.9%12.6%+5.9 points
Abdominal Pain4.9%6.5%9.4%+4.5 points
Decreased Appetite1.6%4.9%8.6%+7 points

Source: Trulicity label (DailyMed).

Hypoglycemia: a comparison of Trulicity and other GLP-1s

Different groups of people were involved in the trials covered by each label. Treat it as a rough guide.

GLP-1 labels and low blood sugar
MedicineHighest rate in the labelDose groupPlaceboPeople in the trials
Saxenda12.6%all doses6.6%Adults with obesity or overweight (weight management)
Wegovy6%2.4 mg2%Adults with obesity or overweight (weight management)
OzempicListed, no rate given–––
RybelsusListed, no rate given–––
MounjaroListed, no rate given–––
ZepboundListed, no rate given–––
FoundayoListed, no rate given–––
TrulicityListed, no rate given–––
VictozaListed, no rate given–––
ByettaListed, no rate given–––

Sources: Wegovy label (DailyMed), Saxenda label (DailyMed).

Source: the FDA label on DailyMed.

Details in the Trulicity label

These are the label's exact words on low blood sugar:

“an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1) and Drug Interactions (7)].”

Source: the FDA label on DailyMed.